New York State Common Retirement Fund
GLUE icon

New York State Common Retirement Fund’s Monte Rosa Therapeutics GLUE Stock Holding History

New York State Common Retirement Fund’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$629K Buy
25,974
+13,800
+113% +$261K ﹤0.01% 1914
2026
Q1 		$200K Hold
12,174
– – ﹤0.01% 2236
2025
Q4 		$191K Hold
12,174
– – ﹤0.01% 2317
2025
Q3 		$90.2K Hold
12,174
– – ﹤0.01% 2673
2025
Q2 		$54.9K Hold
12,174
– – ﹤0.01% 2914
2025
Q1 		$56.5K Hold
12,174
– – ﹤0.01% 2729
2024
Q4 		$84.5K Hold
12,174
– – ﹤0.01% 2661
2024
Q3 		$64.5K Hold
12,174
– – ﹤0.01% 2783
2024
Q2 		$45.5K Buy
12,174
+37
+0.3% +$189 ﹤0.01% 3108
2024
Q1 		$85.6K Sell
12,137
-27
-0.2% -$160 ﹤0.01% 2803
2023
Q4 		$68.7K Sell
12,164
-61
-0.5% -$239 ﹤0.01% 2891
2023
Q3 		$58.6K Buy
12,225
+75
+0.6% +$483 ﹤0.01% 2970
2023
Q2 		$83.2K Sell
12,150
-33
-0.3% -$213 ﹤0.01% 2991
2023
Q1 		$94.9K Sell
12,183
-8,165
-40% -$56.8K ﹤0.01% 2831
2022
Q4 		$155K Sell
20,348
-9
-0% -$75 ﹤0.01% 2832
2022
Q3 		$166K Buy
20,357
+59
+0.3% +$542 ﹤0.01% 2835
2022
Q2 		$196K Buy
20,298
+3,677
+22% +$36.9K ﹤0.01% 2810
2022
Q1 		$233K Buy
16,621
+9,725
+141% +$135K ﹤0.01% 2765
2021
Q4 		$141K Buy
6,896
+2,796
+68% +$58.6K ﹤0.01% 2987
2021
Q3 		$91K Buy
+4,100
New +$118K ﹤0.01% 3167

Other funds holding GLUE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM

New York State Common Retirement Fund's GLUE Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Monte Rosa Therapeutics (GLUE) stake by 113% in Q2 2026, buying an estimated $261K and bringing the position to 25,974 shares worth $629K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

New York State Common Retirement Fund first reported a position in GLUE in Q3 2021 and has held it in 20 quarters since. 31 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • New York State Common Retirement Fund held 25,974 shares of Monte Rosa Therapeutics worth $629K as of Q2 2026.
  • New York State Common Retirement Fund bought 13,800 Monte Rosa Therapeutics shares in Q2 2026, an estimated $261K.
  • Monte Rosa Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1914 holding.
  • New York State Common Retirement Fund first reported a position in Monte Rosa Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 31 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.